The preferred timing of treatment of nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) ...

Results from the first randomized clinical trial in the United States to compare a sirolimus-eluting balloon (DEB) to a ...

New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates ...

Year data from the largest global trial to date using Class I, Level A iFR in heart attack patients shows treating additional ...

A new drug being trialed in heart attack patients could reprogram the immune system to prevent inflammation and heart damage ...

New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates ...

Having more-thorough workup uncovered an unexpected root cause and changed the treatment course for 76% of patients.

The authors collected resource utilization and cost of treatment data (in US dollars, excluding physicians' fees) from the cost accounting systems of two Canadian hospitals (n=215) and seven US ...

The tablets are to reduce the risk of cardiovascular death, myocardial infarction (MI) and stroke in patients with acute ...

Pune, Maharashtra, India, September 17 2020 (Wiredrelease) Prudour Pvt. Ltd –:The latest research report published by Market.us on Geographical and Global Myocardial Infarction Treatment Market is a ...

The American Heart Association has published a scientific statement regarding post-myocardial infarction psychological distress.